RejuPLLA

RejuPLLA is a CE-certified and MFDS-approved sterile absorbable Poly-L-Lactic Acid (PLLA) dermal filler, designed to restore volume, smooth deep wrinkles, and improve facial contours through powerful collagen stimulation.

Formulated with PLLA microspheres, CMC, and Mannitol, RejuPLLA leverages PSMMT (PRP Science Microsphere Micelle Technology) for maximum biocompatibility, safe integration, and minimized side effects such as nodules. Its optimized micellar structure ensures smooth injection, long-lasting performance, and natural results.

Key Benefits:

• Collagen Regeneration – Stimulates fibroblasts and M2 macrophage activity to promote long-term collagen production.

• Volume Restoration – Effectively treats facial lipoatrophy, volume defects, and deep wrinkles.

• Durability – Results last 12–24 months after a treatment cycle, with collagen support continuing over time.

• Safety & Biocompatibility – Proven low inflammation levels compared to PDLLA and PDLA; biodegradable and naturally eliminated as CO₂ and H₂O.

• High Efficacy – Clinically demonstrated to significantly increase soluble and total collagen levels while reducing visible signs of aging.

Treatment Protocol:

• Injected into dermis or subcutaneous tissue using a 26G cannula or needle.

• Initial results appear after 1–3 months, with optimal results after 3 treatment sessions spaced 4 weeks apart.

• Maintenance treatments every 6–12 months help sustain collagen activation and youthful results.

Specifications:

• Major Components: PLLA + CMC + Mannitol

• Particle Size: 30–60 μm

• Dose: 365 mg/vial

• Target Areas: Deep wrinkles, volume defects, facial lipoatrophy

• Duration: 12–24 months